Delivery Order SPE2DB25D7067-SPE2DB25FSWBW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,233.66 for MOVIPREP powder packets. Awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, this non-set-aside contract represents a small-value procurement from DLA's broader medical supply operations. The delivery order is performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.32 to AmerisourceBergen Drug Corp for MOVIPREP powder packets, a bowel preparation medication commonly used in medical procedures. This firm fixed price contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a small-value transaction executed through the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (Contract No. SPE2DX15D1021|SPE2DX24FHQUK) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,956,715 units of MOVIPREP Powder Packets. The delivery order has a ceiling value of $1,068.90 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $15,620.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA to provide a range of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, with a potential value of $1,413.76, is for the provision of MOVIPREP POWDER PACKETS to be delivered by February 9, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a potential value of $3,467.31 and a completion date of March 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- This federal contract award, valued at $2,462.95, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, and has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,153.95 order is for the supply of MOVIPREP powder packets, a specialty pharmaceutical product, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,306.70, is for the supply of MOVIPREP Powder Packets, a medical product. The contract has a completion date of April 26, 2023 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOVIPREP POWDER PACKETS. The contract has a completion date of February 29, 2024 and a potential value of $4,298.25. This contract is not a set-aside award. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSWBWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of MOVIPREP powder packets, a bowel preparation medication, with a ceiling value of $1,233.66. This firm fixed-price contract, executed without a set-aside designation, represents a competitively awarded delivery order under the company's existing pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a critical distributor for federal military and veteran healthcare systems, AmerisourceBergen fulfills delivery orders across a broad portfolio of pharmaceutical products and medical supplies through this strategic vehicle, which enables the company to support Defense Health Agency requirements and other government healthcare customers globally. The contract reflects DLA's ongoing reliance on established pharmaceutical vendors to maintain consistent supply of essential medical commodities to military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/18/25 |